Skip to content
Screener

Medtronic MDT Other operating segment — Reportable segment operating profit

Other segment segments

Cardiovascular
$1.07B+11.8%
Neuroscience
$879M+2.4%
Medical Surgical
$605M+5.2%
Diabetes
$57M+14.0%

Similar metrics at other companies

Elevance Health logo
ELVCarelonRx Segment — Reportable segments’ operating gain
$582M+8.6%
ARE
AREReportable Segment, Aggregation before Other Operating Segment — Reportable segment net operating income (reportable segment profit or loss)
$413.14M-16.2%
Elevance Health logo
ELVCarelon Services Segment — Reportable segments’ operating gain
$366M-8.5%
Elevance Health logo
ELVHealth Benefits Segment — Reportable segments’ operating gain
$896M-42.6%
NewMarket logo
NEUAll Other — Segment operating profit
-$212K+81.9%
California Resources logo
CRCTotal Reportable Segments — Segment profit or (loss)
$270M+12.0%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Medtronic’s 10-Q, filed February 24, 2026.

Filed
Feb 24, 2026, 4:18 PM EST
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-011107
(in millions)CardiovascularNeuroscienceMedical SurgicalDiabetesTotal
Other segment items(2)(14)126(2)3
Reportable segment operating profit$899$737$499$57$2,192
Reconciliation of segment profit / (loss)
Other operating segment profit (loss)(1)(1)
Currency and other(13)
Interest expense, net(181)
Other non-operating income, net121
Amortization of intangible assets(441)

Item 1. Financial Statements

FAQ

What is Medtronic's other operating segment — reportable segment operating profit?
Medtronic (MDT) reported other operating segment — reportable segment operating profit of -$1M in Q4 2025.
How has Medtronic's other operating segment — reportable segment operating profit changed year-over-year?
Medtronic's other operating segment — reportable segment operating profit decreased by 107.7% year-over-year, from $13M to -$1M.
What is the long-term trend for Medtronic's other operating segment — reportable segment operating profit?
Over 2 years (2022 to 2024), Medtronic's other operating segment — reportable segment operating profit has grown at a -43.2% compound annual growth rate (CAGR), from -$31M to $10M.
What does other operating segment — reportable segment operating profit mean?
This metric measures the operating income generated by the company's secondary business segments after accounting for direct operating expenses. It provides insight into the profitability and operational efficiency of business units that fall outside the primary reporting segments. Investors use this to evaluate the margin profile of the company's diversified portfolio.

Ask your AI about Medtronic's other operating segment — reportable segment operating profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude